Fras JP, Davies MJ, Rosenstock J, Prez Manghi FC, Fernndez Land L, Bergman BK, Liu B, Cui X, Brown KS, Grandy S, Urva S
B.et al
Personalized Dosing With PlexusDx Genetic Insights The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
GLP-1 can alter the expression of GLP-1 receptors on the surface of VANs, and binding of GLP-1 to these receptors results in transmission of signals to the brain
Focus on obesity treatment for lasting lifestyle change Obesity in adults: Pharmacologic options for successful management Caring for adult patients with obesity in primary care The benefits of GLP-1 RAs extend beyond glycemic control
It stays mostly within the metabolic and endocrine systems and does not pose a known risk to the patients who receive plasma treatments